Acenomac 4mg Tablet

Acenomac 4mg Tablet is a high-strength oral anticoagulant prescribed for the prevention and treatment of blood clot-related disorders such as deep vein thrombosis (DVT), pulmonary embolism (PE), and stroke prevention in atrial fibrillation (AF). It belongs to the vitamin K antagonist (VKA) class of blood thinners and works by blocking the synthesis of vitamin K-dependent clotting factors in the liver. This action helps to reduce the risk of potentially life-threatening clot formation in the arteries and veins.

This 4 MG formulation is typically used in patients who require higher-dose anticoagulation therapy due to individual treatment responses, body weight, or specific medical conditions. Acenomac 4mg Tablet allows for stronger anticoagulant effects and is often utilized in dose titration strategies under close medical supervision.

Because Acenocoumarol has a narrow therapeutic index, it must be used alongside regular INR (International Normalized Ratio) monitoring to ensure safe and effective anticoagulation. Doses may be adjusted depending on lab results, dietary habits, concurrent medications, liver function, and genetic sensitivity to the drug.

Acenocoumarol is an effective alternative to other oral anticoagulants such as warfarin and is widely used in many countries for long-term blood thinning therapy. However, its safety relies heavily on patient compliance, dietary consistency, and frequent INR monitoring.